Brian J. LeMay

Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats

A. Makriyannis, J. Wood, S. Vadivel, 2014, Psychopharmacology.

AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice

S. Nikas, A. Makriyannis, T. Järbe, 2012, Psychopharmacology.